-
The first domestically produced new crown neutralizing antibody combination therapy was approved by the State Food and Drug Administration
Time of Update: 2022-02-25
It is reported that the State Food and Drug Administration, in accordance with the relevant provisions of the "Drug Administration Law" and in accordance with the special drug approval procedures, conducted emergency review and approval, and approved the combination of the above two drugs for the treatment of mild and common types with progression to severe (including hospitalization or Death) adults and adolescents (12-17 years old, body weight ≥40kg) patients with novel coronavirus infection (COVID-19) with high risk factors .
-
The first domestically produced COVID-19 neutralizing antibody combination therapy was approved by the National Food and Drug Administration
Time of Update: 2021-12-30
It is reported that the State Food and Drug Administration, in accordance with the relevant provisions of the Drug Administration Law, in accordance with the special drug approval procedures, conducts emergency review and approval, and approves the above two drugs to be used in combination to treat mild and common types with progress to severe (including hospitalization or Death) Adults and adolescents (12-17 years old, weight ≥40kg) with high-risk factors, patients with novel coronavirus infection (COVID-19) .
-
Hepatitis B innovative therapy! Geli subcutaneous injection of PD-L1 antibody asc22 was approved
Time of Update: 2020-01-24
January 24, 2020 / BIOON / -- ascletis recently announced that its subcutaneous injection of PD-L1 antibody asc22 has been approved by China National Drug Administration (nmpa) to carry out clinical t
-
It is found that sesame antibody test can accurately predict whether children with food allergy are allergic to sesame
Time of Update: 2019-11-07
Recently, published in the Journal of Pediatrics alliance and immunology, researchers from the National Institutes of health found that sesame allergy is very common in children with other food allerg
-
Sansheng pharmaceutical's recombinant humanized anti-il-17a monoclonal antibody was approved by the clinical trial of the State Food and drug administration
Time of Update: 2019-08-02
August 2, 2019 / Meitong news agency / -- China's leading biopharmaceutical company Sansheng Pharmaceutical (01530 HK) announced today that the company's self-developed recombinant humanized anti inte